{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:34:28Z","timestamp":1781976868726,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009593","name":"Dyslexia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["RL-15-1579"],"award-info":[{"award-number":["RL-15-1579"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.sapharm.2023.10.015","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:25:57Z","timestamp":1698557157000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development and validation of a theory-based questionnaire examining barriers and facilitators to discontinuing long-term benzodiazepine receptor agonist use"],"prefix":"10.1016","volume":"20","author":[{"given":"Tom","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00edn","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Presseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-0112","authenticated-orcid":false,"given":"Cathal","family":"Cadogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.10.015_bib1","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.sapharm.2023.10.015_bib2","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.3399\/BJGP.2021.0561","article-title":"Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink","volume":"72","author":"Archer","year":"2022","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.sapharm.2023.10.015_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pds.4551","article-title":"Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: a national register study for 2006 to 2014","volume":"27","author":"Kurko","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2023.10.015_bib4","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bcp.13570","article-title":"Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015","volume":"84","author":"Cadogan","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.10.015_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust Prescr"},{"key":"10.1016\/j.sapharm.2023.10.015_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr Opin Psychiatr"},{"key":"10.1016\/j.sapharm.2023.10.015_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"An updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R"},{"issue":"1","key":"10.1016\/j.sapharm.2023.10.015_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hex.13392","article-title":"\u2018I just thought that it was such an impossible thing\u2019: a qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the Theoretical Domains Framework","volume":"25","author":"Lynch","year":"2022","journal-title":"Health Expect"},{"issue":"4","key":"10.1016\/j.sapharm.2023.10.015_bib9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/hex.13547","article-title":"Supporting sAFE and GradUAl ReDuctIon of loNG-term BenzodiaZepine Receptor Agonist uSe: development of the SAFEGUARDING-BZRAs toolkit using a co-design approach","volume":"25","author":"Lynch","year":"2022","journal-title":"Health Expect"},{"key":"10.1016\/j.sapharm.2023.10.015_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijnurstu.2012.09.010","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"50","author":"Craig","year":"2013","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.sapharm.2023.10.015_bib11","first-page":"77","article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems","volume":"12","author":"Atkins","year":"2017","journal-title":"Imp Sci"},{"key":"10.1016\/j.sapharm.2023.10.015_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/qshc.2004.011155","article-title":"Making psychological theory useful for implementing evidence based practice: a consensus approach","volume":"14","author":"Michie","year":"2005","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.sapharm.2023.10.015_bib13","first-page":"37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research","volume":"7","author":"Cane","year":"2012","journal-title":"Imp Sci"},{"key":"10.1016\/j.sapharm.2023.10.015_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzab106","article-title":"How is the Theoretical Domains Framework applied in designing interventions to support healthcare practitioner behaviour change? A systematic review","volume":"33","author":"Dyson","year":"2021","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.sapharm.2023.10.015_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12160-013-9486-6","article-title":"The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions","volume":"46","author":"Michie","year":"2013","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.sapharm.2023.10.015_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12966-017-0499-6","article-title":"Measuring implementation behaviour of menu guidelines in the childcare setting: confirmatory factor analysis of a theoretical domains framework questionnaire (TDFQ)","volume":"14","author":"Seward","year":"2017","journal-title":"Int J Behav Nutr Phys Activ"},{"key":"10.1016\/j.sapharm.2023.10.015_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1479-5868-10-74","article-title":"Development and initial validation of the determinants of physical activity questionnaire","volume":"10","author":"Taylor","year":"2013","journal-title":"Int J Behav Nutr Phys Activ"},{"key":"10.1016\/j.sapharm.2023.10.015_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320981174","article-title":"The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?","volume":"11","author":"White","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.sapharm.2023.10.015_bib19","series-title":"Principles and Practice of Structural Equation Modeling","author":"Kline","year":"2005"},{"issue":"3","key":"10.1016\/j.sapharm.2023.10.015_bib20","article-title":"Methods to increase response to postal and electronic questionnaires","author":"Edwards","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2023.10.015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40271-016-0182-z","article-title":"A systematic review and meta-synthesis of patients' experiences and perceptions of seeking and using benzodiazepines and z-drugs: towards safer prescribing","volume":"10","author":"Sirdifield","year":"2017","journal-title":"Patient"},{"key":"10.1016\/j.sapharm.2023.10.015_bib22","first-page":"11","article-title":"Discriminant content validity of a theoretical domains framework questionnaire for use in implementation research","volume":"9","author":"Huijg","year":"2014","journal-title":"Imp Sci"},{"key":"10.1016\/j.sapharm.2023.10.015_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40266-016-0410-1","article-title":"Development and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers","volume":"33","author":"Reeve","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2023.10.015_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11096-012-9704-5","article-title":"Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire","volume":"35","author":"Reeve","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2023.10.015_bib25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.sapharm.2023.05.010","article-title":"Adaptation and validation of the revised Patients' Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists","volume":"19","author":"P\u00e9tein","year":"2023","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2023.10.015_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/2045125321991274","article-title":"What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications","volume":"11","author":"Framer","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.sapharm.2023.10.015_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3399\/bjgp21X716309","article-title":"Tapering antidepressants: why do tens of thousands turn to Facebook groups for support?","volume":"71","author":"White","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.sapharm.2023.10.015_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123004679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123004679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:32:52Z","timestamp":1761557572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123004679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1551741123004679"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.10.015","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a theory-based questionnaire examining barriers and facilitators to discontinuing long-term benzodiazepine receptor agonist use","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}